Searchable abstracts of presentations at key conferences on calcified tissues

ba0003pp169 | Cell biology: osteoclasts and bone resorption | ECTS2014

Mechanosensitive TRP channels are required for Ca2+ signaling in osteoclastogenesis

Yang Yu-Mi , Lee Jiae , Shin Dong Min

Bone remodeling and maintenance require a fine balance between bone formation of osteoblasts and resorption of osteoclasts. Therefore, various skeletal disorders cause by imbalanced differentiation and activities of these cells. RANKL (receptor activator of NF-kB ligand) induces Ca2+ oscillations and activates NFATc1 (nuclear factor of activated T cells i) during osteoclast differentiation. Although Ca2+ oscillations play a key role for osteoclastogenesis...

ba0003pp171 | Cell biology: osteoclasts and bone resorption | ECTS2014

The purinergenic receptor P2Y14 is essential for RANKL-induced osteoclastogenesis

Park Jin Hee , Jung Eutteum , Lee Soo Young

The P2Y14 (purinergic receptor P2Y, G protein coupled, 14) receptor for UDP-glucose and other UDP-sugars has been implicated in the regulation of the stem cell compartment as well as neuroimmune function. However, the role of P2Y14 in osteoclast formation is completely unknown. We found that RANKL selectively induced P2Y14 among seven mammalian P2Y receptors when analysed at both the mRNA and protein level, but inhibitors of the MAP pathway suppressed induction of P2Y14 protei...

ba0003pp176 | Cell biology: osteocytes | ECTS2014

Effects of osteocyte apoptosis and mechanical strain on osteoblast proliferation and migration

Ko Seong-Hee , Lee Hee Su , Baek Kyunghwa

There are several evidences that osteocyte plays a critical role in bone remodeling. Healthy or apoptotic osteocytes can send signals to other bone surface cells like osteoblasts, osteoclasts, osteoclast precursors and bone lining cells through their networking in canaliculi. Therefore, to determine the role for osteocytes in bone remodeling, we examined the effect of healthy and apoptotic osteocytes on osteoblasts proliferation and recruitment. In addition, the effects of mec...

ba0003pp268 | Osteoporosis: pathophysiology and epidemiology | ECTS2014

BMD and biochemical bone markers in premenopausal amenorrhea

Kang Byung-Moon , Kwon Su-Kyoung , Lee Kyung-Hee

Objectives: This study was designed to investigate the prevalence of low bone mass, the influence of amenorrhea on bone mineral density (BMD), and the cause of amenorrhea that provoke the severe low bone mass in premenopausal women.Materials and methods: One hundred and seventy one women diagnosed with amenorrhea in premenopausal women were included in this study. All patients underwent history taking, gynecological examination, and check serum hormone l...

ba0004p117 | (1) | ICCBH2015

Familial hypocalciuric hypercalcemia in two Chinese families -- common and uncommon features

Lee Lai-Ka , Yau Ho-Chung , Yuen Liz

Background: Familial hypocalciuric hypercalcemia (FHH) is a rare autosomal dominant condition with an estimated prevalence of 1 in 78,000. The commonest cause of FHH is inactivating mutations of the calcium-sensing receptor (CASR) gene, with the rest mostly caused by missense mutations of the GNA11 and AP2S1 genes. FHH is characterized by persistent mild-to-moderate hypercalcemia, hypocalciuria with calcium-creatinine clearance ratio ⩽0.01. The disease runs a benign cou...

ba0005p156 | Cell biology: osteoblasts and bone formation | ECTS2016

The differential effects of zoledronate and etidronate on the in vivo early osseous healing process of an extracted socket and a tibial defect

Kim In Sook , Lim Shin Saeng , Lee Beomseok , Hwang Soon Jung

Bisphosphonates (BPs) are widely used for treating osteoporosis and preventing osseous metastasis or hypercalcemia in cancers. However, osteonecrosis of the jaw in patients treated with BP after dentoalveolar surgery has been increasing, especially in those treated with strong BPs such as zoledronate (ZA). The pathobiology underlying the occurrence of osteonecrosis only in the jaw bone remains unclear. The objective of this study was to compare the effects of BPs on the in...

ba0005p338 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

Nonalcoholic fatty liver disease is associated with postmenopausal osteoporosis

Moon Seong-Su , Lee Young-Sil , Kim Taekyoon

Osteoporosis is known to be associated with metabolic diseases characterized by insulin resistance, such as central obesity, diabetes, and metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) is also increased in such insulin resistant conditions. However, little is known about whether osteoporosis and nonalcoholic fatty liver disease are etiologically related to each other or not. We investigated whether bone mineral density(BMD) is associated with NAFLD in pre- and ...

ba0005p348 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

The relationship between osteoporosis and urine ACR in postmenopausal women with type 2 diabetes

Cho Nanhee , Kim Hanbyul , Lee Yeyeon , Cho Hochan

Purpose: Osteoporosis is a progressive bone disease that is characterized by a decrease in bone mass, density and destruction of microstructure, which can lead to an increased risk of fracture. Although many studies have been published about relationship between end-stage renal disease and osteoporosis, but research on the relationship between proteinuria and the prevalence of osteoporosis is still lacking.Methods: We assessed 91 postmenopausal women wit...

ba0005p383 | Osteoporosis: treatment | ECTS2016

A interventional study in a real life setting to assess the clinical efficacy and effect to fracture in the 1 year after the injection of zoledronic acid in osteoporotic patients with long bone or spine, pelvic fractures

Lee Jaewon , Kim Joonguk , Park Ki-chul , Park Ye-Soo

Objectives: There are some studies that evaluated changes of bone marrow density (BMD) and re-fracture after zoledronic acid injection. However, there is no study that showed about the fracture on all of the body, fracture healing, and improvement of clinical symptom after zoledronic acid injection. In this study, authors evaluated the 1 year BMD change, changes of lumbar pain in lumbar spine fractures, effects on fracture healing, re-fracture and additional fracture on other ...

ba0006lb13 | (1) | ICCBH2017

Low dose of intravenous pamidronate therapy in quadriplegic children with osteoporosis

Moon Soonjung , Kim Soonki , Kwon Youngse , Lee Jieun

Objectives: Quadriplegic children are more susceptible to osteoporosis because of various risk factors for the inhibition of bone metabolism. The importance of bone metabolism is being emphasized based on extending life span of the patients but research on this area is insufficient. Intravenous (IV) pamidronate is well known as an effective treatment for pediatric osteoporosis, but there are no treatment guidelines for accurate dose capacity and duration in quadriplegic childr...